DOCSLIB.ORG

Expression of the <Alpha>6 Integrin Confers Papillomavirus Binding

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Expression of the <Alpha>6 Integrin Confers Papillomavirus Binding Virology 261, 271–279 (1999) Article ID viro.1999.9825, available online at http://www.idealibrary.com on View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Expression of the a6 Integrin Confers Papillomavirus Binding upon Receptor-Negative B-Cells Nigel A. J. McMillan,*,1 Elizabeth Payne,* Ian H. Frazer,* and Magnus Evander† *Centre for Immunology and Cancer Research, Department of Medicine, University of Queensland, Brisbane, Australia; and †Department of Virology, Umeå University, Umeå, Sweden Received March 26, 1999; returned to author for revision April 27, 1999; accepted May 26, 1999 Papillomaviruses (PV) bind to a wide range of cell lines in a specific and saturable manner. We have recently identified a candidate receptor for papillomavirus as the a6 integrin (Evander et al., J. Virol. 71, 2449–2456, 1997). We have further investigated the role the a6 integrin plays in PV binding. Here we show that the cells expressing the a6 integrin, partnered with either the b4 integrin or the b1 integrin, are equally able to bind PV HPV6b L1 virus-like particles, indicating that the beta partner does not play a major role in virus binding. In order to provide definitive evidence that the a6 integrin is required for PV binding we undertook to genetically complement the receptor-negative B-cell line DG75 by expressing the human a6A gene. The transduction of the a6 integrin gene into DG75 cells results in the cell surface expression of the a6 protein and this expression confers upon DG75 cells the ability to bind laminin, a normal ligand for a6 integrin. Furthermore, the a6 protein is partnered with the b1 integrin in DG75 cells. Finally, we show that the DG75-a6 cells were able to bind papillomavirus VLPs and this binding was inhibited by a functionally blocking anti-a6 antibody. Together these data indicate that the a6 integrin is a primary cell receptor for papillomaviruses and is both necessary and sufficient for PV binding. © 1999 Academic Press INTRODUCTION The first step in viral infection is the binding of the virus to a host cell. Previous reports have shown that Papillomaviruses (PV) are nonenveloped dsDNA tumor viruses that cause a range of proliferative lesions upon HPV binds to a wide variety of cell lines to varying infection of epithelial cells (Howley, 1996). They infect a degrees (Mu¨ller et al., 1995; Qi et al., 1996; Roden et al., wide range of species but exhibit a high degree of 1994a; Volpers et al., 1995). However, the greatest bind- species specificity (Shah and Howley, 1996). Over 70 ing was observed with epithelial and mesenchymal cells. different human subtypes of PV have been isolated and The PV particle is made of two proteins, L1 and L2. L1 is formally described (de Villiers, 1994; Halpern et al., 1996), the major coat protein, while L2 is thought to form a link each infecting either mucosal or cutaneous epithelium at between the viral DNA and the viral particle (Zhou et al., distinct sites. For example, HPV11 infects mucosal epi- 1994, 1991). PV particles bound in a saturable manner, 4 thelial cells of the genital tract but does not infect cuta- with 1–2 3 10 receptors/cell, while linear L1 protein neous epithelium from other body sites (Kreider et al., binding was nonsaturable (Qi et al., 1996). Binding was 1987). PVs are the causative agent of warts (plantar, trypsin-sensitive and this, along with the wide degree of laryngopharyngeal, and genital) and are also the critical binding to cells from various species, suggests that the factor in the formation of anogenital cancer (Zur Hausen, receptor is a widely conserved protein (Qi et al., 1996; 1994). The cancer-associated subtypes (HPV16, HPV18, Volpers et al., 1995). Furthermore, the same receptor HPV33, etc.) are termed high-risk, while all others are appears to be utilized by all PVs for binding, as particles termed low-risk (Howley, 1996; Shah and Howley, 1996; from one PV species or subtype will inhibit the binding of Zur Hausen, 1994). Unfortunately, the lack of in vitro another (Mu¨ller et al., 1995; Roden et al., 1994a). For replication systems has meant that many critical aspects example, HPV6b inhibited the binding of HPV-11, -16, and of the virus life cycle remain unknown and therefore are BPV (Mu¨ller et al., 1995). not readily amenable to manipulation. However, the ad- We have recently identified the a6 integrin as a can- vent of virus-like particle technology has allowed some didate receptor for papillomavirus (Evander et al., 1997). aspects of PV binding and internalization to be ad- This finding was based on the observation that PV virus- dressed. like particles (VLPs) interacted with a protein consistent in size with the a6 integrin and were able to be coim- a 1 munoprecipatated with anti- 6 antibodies, and function- To whom correspondence and reprint requests should be ad- ally blocking antibodies against a6 were able to reduce dressed at U.Q. Dept. of Medicine, PA Hospital, Ipswich Rd., Brisbane, a QLD 4102 Australia. Fax: 161 7 32 40 59 46. E-mail: nmcmillan@ VLP binding to cells. Furthermore, 6 and VLP binding medicine.pa.uq.edu.au. were colocalized upon the cell surface of the basal and 0042-6822/99 $30.00 271 Copyright © 1999 by Academic Press All rights of reproduction in any form reserved. 272 MCMILLAN ET AL. suprabasal epithelial cells (the same cells to which viral RESULTS replication is restricted) and the natural ligand for a6, laminin, blocked VLP attachment. Finally, a binding-neg- Binding of PV to cultured cell lines correlates with a ative B-cell line, DG75, did not express the a6 integrin. expression of 6 integrin The a6 integrin is termed the epithelial integrin, as it is We have previously shown that HPV is able to bind expressed most highly upon epithelial cells, the very to cells that express the a6b4 integrin and that ligands same cell type that binds PVs to the highest degree and of, and antibodies against, a6 are able to block virus within which primary infection is known to occur and to binding, leading to the suggestion that a6b4 is the PV which vegetative DNA replication is restricted. receptor. However, a6b4 has a limited tissue distribu- The a6 integrin partners with a beta integrin subunit, tion (epithelial, mesenchymal, and some neuronal either b4orb1. The a6b1 integrin is expressed on a cells), while HPV binding is known to occur in a wide wide range of cells, including platelets, lymphocytes, variety of cells. The a6 integrin is able to heterodimer- macrophages, oocytes, and endothelial cells, whereas ize with two beta partners, b1orb4. The a6b1 has a a6b4 is relatively restricted to epithelial, mesenchy- wide tissue distribution, including platelets, lympho- mal, and some neuronal cells. In stratified squamous cytes, macrophages, oocytes, and endothelial cells. epithelium the a6b4 complex is an integral part of the Thus, HPV may be able to bind to many cell types via a b hemidesmosome (Sonnenberg et al., 1991) and as a the 6 1 integrin. In order to test this possibility we receptor for laminins (Niessen et al., 1994) is involved analyzed two cell lines, COS-7 and HaCaT, which have been reported to express a6b1ora6b4 integrin, re- in the interaction of epithelial cells with the basement spectively. We found that HaCaT cells express high membrane. The cells which have the highest degree of levels of a6, b1, and b4 integrin. It should be noted that PV binding match the expression profile of a6b4, al- a6 binds preferentially with b4 due to its higher affinity though PV does bind to cells expressing a6b1. Thus, for b4 than b1. As expected COS-7 cells express both the expression of a 6 is widespread and highly con- a6 and b1 integrin but do not express b4 integrin (Fig. served between species, matching the criteria from 1A). We then tested these cells for their ability to bind previous in vitro results. HPV VLPs. Cells were exposed to VLPs at 4°C and We have previously proposed a model for PV infection washed, and VLPs detected using an L1-specific a in which virus particles bind to the 6 integrin during monoclonal antibody. It can be seen that both HaCaT wound healing and are endocytosed during cell migra- and COS-7 bind VLPs, while the receptor-negative cell tion. The a6b4 integrin is believed to be attached to the line DG75 does not (Fig. 1B). This result indicates that microfilament network via the hemidesmosome (Gian- the beta partner does not appear to be important for cotti et al., 1992; Spinardi et al., 1993) and this may binding of VLPs but rather that it is the presence of a6 provide an explanation for the observation that cytocha- that is required. lasin B inhibits papillomavirus uptake in CV-1 cells (Zhou et al., 1995), suggesting that PV particles endocytosed Expression of a6 integrin in DG75 cells together with a6b4 integrin may be transported to the a cell nucleus via a microfilament-dependent pathway. In order to prove that 6 is a critical factor required However, while our data suggest that a6isanHPV for PV binding we undertook to genetically comple- a receptor it does not constitute definitive evidence that ment binding by transfecting the 6 gene into a cell line not able to bind PV. DG75 is a human B-cell line this is the case. Therefore, we undertook to genetically that does not express a6 integrin (Evander et al., complement the ability to bind HPV by expressing the a6 1997). The human a6A gene was cloned into the vector gene in the receptor-negative B-cell line DG75.
Load more

Recommended publications
  • Altered Integrin Alpha 6 Expression As a Rescue for Muscle Fiber Detachment in Zebrafish (Danio Rerio)
    The University of Maine DigitalCommons@UMaine Honors College Spring 2014 Altered Integrin Alpha 6 Expression As A Rescue For Muscle Fiber Detachment In Zebrafish (Danio Rerio) Rose E. McGlauflin Follow this and additional works at: https://digitalcommons.library.umaine.edu/honors Part of the Animal Diseases Commons, and the Musculoskeletal Diseases Commons Recommended Citation McGlauflin, Rose E., Alter" ed Integrin Alpha 6 Expression As A Rescue For Muscle Fiber Detachment In Zebrafish (Danio Rerio)" (2014). Honors College. 140. https://digitalcommons.library.umaine.edu/honors/140 This Honors Thesis is brought to you for free and open access by DigitalCommons@UMaine. It has been accepted for inclusion in Honors College by an authorized administrator of DigitalCommons@UMaine. For more information, please contact [email protected]. ALTERED INTEGRIN ALPHA 6 EXPRESSION AS A RESCUE FOR MUSCLE FIBER DETACHMENT IN ZEBRAFISH (DANIO RERIO) by Rose E. McGlauflin A Thesis Submitted in Partial Fulfillment of the Requirements for a Degree with Honors (Biology) The Honors College University of Maine May 2014 Advisory Committee: Clarissa A. Henry, Ph.D., Associate Professor of Biological Sciences, Advisor Mary S. Tyler, Ph.D., Professor of Zoology Mary Astumian, Henry Lab Manager Michelle Smith, Ph.D., Assistant Professor of Biological Sciences Mark Haggerty, Ph.D., Honors Preceptor for Civic Engagement Abstract Cells adhere to their extracellular matrix by way of integrins, transmembrane molecules that attach the cytoskeleton to the extracellular basement membrane (one kind of extracellular matrix). In some muscular dystrophies, specific integrins are disrupted and muscle fibers detach from the myotendenous junction and degenerate. This integrin disruption causes a constant cycle of regeneration and degeneration, which greatly harms the tissue over time.
    [Show full text]
  • 2335 Roles of Molecules Involved in Epithelial/Mesenchymal Transition
    [Frontiers in Bioscience 13, 2335-2355, January 1, 2008] Roles of molecules involved in epithelial/mesenchymal transition during angiogenesis Giulio Ghersi Dipartimento di Biologia Cellulare e dello Sviluppo, Universita di Palermo, Italy TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Extracellular matrix 3.1. ECM and integrins 3.2. Basal lamina components 4. Cadherins. 4.1. Cadherins in angiogenesis 5. Integrins. 5.1. Integrins in angiogenesis 6. Focal adhesion molecules 7. Proteolytic enzymes 7.1. Proteolytic enzymes inhibitors 7.2. Proteolytic enzymes in angiogenesis 8. Perspective 9. Acknowledgements 10. References 1.ABSTRACT 2. INTRODUCTION Formation of vessels requires “epithelial- Growth of new blood vessels (angiogenesis) mesenchymal” transition of endothelial cells, with several plays a key role in several physiological processes, such modifications at the level of endothelial cell plasma as vascular remodeling during embryogenesis and membranes. These processes are associated with wound healing tissue repair in the adult; as well as redistribution of cell-cell and cell-substrate adhesion pathological processes, including rheumatoid arthritis, molecules, cross talk between external ECM and internal diabetic retinopathy, psoriasis, hemangiomas, and cytoskeleton through focal adhesion molecules and the cancer (1). Vessel formation entails the “epithelial- expression of several proteolytic enzymes, including matrix mesenchymal” transition of endothelial cells (ECs) “in metalloproteases and serine proteases. These enzymes with vivo”; a similar phenotypic exchange can be induced “in their degradative action on ECM components, generate vitro” by growing ECs to low cell density, or in “wound molecules acting as activators and/or inhibitors of healing” experiments or perturbing cell adhesion and angiogenesis. The purpose of this review is to provide an associated molecule functions.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Kruppel-Like Factor 9 Inhibits Glioblastoma Stemness
    KRUPPEL-LIKE FACTOR 9 INHIBITS GLIOBLASTOMA STEMNESS THROUGH GLOBAL TRANSCRIPTION REPRESSION AND INHIBITION OF INTEGRIN ALPHA 6 AND CD151 By Jessica Tilghman A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland October, 2015 Abstract Glioblastoma (GBM) stem cells (GSCs) represent tumor-propagating cells with stem-like characteristics (stemness) that contribute disproportionately to GBM drug resistance and tumor recurrence. Understanding the mechanisms supporting GSC stemness is important for developing novel strategies that target tumor propagation to inhibit cancer progression and improve patient survival. Krüppel-like factor 9 (KLF9) has emerged as a regulator of cell differentiation, neural development, and oncogenesis; however, the molecular basis for KLF9’s diverse contextual functions has been unclear. We establish for the first time a genome-wide map of KLF9-regulated targets in human glioblastoma stem-like cells, and show that KLF9 functions as a transcriptional repressor and thereby regulates multiple signaling pathways involved in oncogenesis and regulation of cancer stem-like phenotype. A detailed analysis of two novel KLF9 targets suggests that KLF9 inhibits glioma cell stemness by repressing expression of integrin α6 and CD151. The expression of one candidate KLF9 target gene ITGA6 coding for integrin α6 was verified to be downregulated by KLF9 in GSCs. ITGA6 transcription repression by KLF9 altered GBM neurosphere cell behavior as evidenced by reduced cell adhesion to and migration through membrane coated with the integrin α6 ligand laminin. Forced expression of integrin α6 partially rescued GBM neurosphere cells from the differentiating and adhesion/migration-inhibiting effects of KLF9.
    [Show full text]
  • Integrins: Roles in Cancer Development and As Treatment Targets
    British Journal of Cancer (2004) 90, 561 – 565 & 2004 Cancer Research UK All rights reserved 0007 – 0920/04 $25.00 www.bjcancer.com Minireview Integrins: roles in cancer development and as treatment targets 1 ,1,2 H Jin and J Varner* 1John and Rebecca Moores Comprehensive Cancer Center, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0912, USA; 2Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0912, USA The integrin family of cell adhesion proteins promotes the attachment and migration of cells on the surrounding extracellular matrix (ECM). Through signals transduced upon integrin ligation by ECM proteins or immunoglobulin superfamily molecules, this family of proteins plays key roles in regulating tumour growth and metastasis as well as tumour angiogenesis. Several integrins play key roles in promoting tumour angiogenesis and tumour metastasis. Antagonists of several integrins (a5b1, avb3 and avb5) are now under evaluation in clinical trials to determine their potential as therapeutics for cancer and other diseases. British Journal of Cancer (2004) 90, 561 – 565. doi:10.1038/sj.bjc.6601576 www.bjcancer.com & 2004 Cancer Research UK Keywords: angiogenesis; metastasis; apoptosis; integrin a5b1; integrin avb3 During the last 10 years, novel insights into the mechanisms sequences (e.g., integrin a4b1 recognises EILDV and REDV in that regulate cell survival as well as cell migration and invasion alternatively spliced CS-1 fibronectin). Inhibitors of integrin have led to the development of novel integrin-based therapeutics function include function-blocking monoclonal antibodies, pep- for the treatment of cancer. Several integrins play important tide antagonists and small molecule peptide mimetics matrix roles in promoting cell proliferation, migration and survival (reviewed in Hynes, 1992; Cheresh, 1993).
    [Show full text]
  • Cell Adhesion and Angiogenesis
    Cell adhesion and angiogenesis. J Bischoff J Clin Invest. 1997;99(3):373-376. https://doi.org/10.1172/JCI119168. Perspective Find the latest version: https://jci.me/119168/pdf Perspectives Series: Cell Adhesion in Vascular Biology Cell Adhesion and Angiogenesis Joyce Bischoff Department of Surgery, Children’s Hospital and Harvard Medical School, Children’s Hospital, Boston, Massachusetts 02115 Introduction and postcapillary venules (3). Thus, the formation of a new mi- Angiogenesis is the growth of new capillary blood vessels from crovessel requires a number of interactions that must be coor- preexisting capillaries and postcapillary venules. This process dinated in a spatially and temporally specified manner. These is critical for normal growth and development and in protec- adhesion events are likely mediated by endothelial cell adhe- tive responses such as wound healing and inflammation. In sion molecules and ECM molecules that provide instructions healthy adults, angiogenesis does not normally occur except in to the endothelial cells as they migrate into the perivascular certain phases of the female reproductive cycle. However, ab- space and assemble into new vessels with surrounding peri- errant angiogenesis can occur in a variety of pathologic set- cytes. tings. These include the neovascularization of solid tumors, the Cell adhesion and endothelial cell growth growth of vessels into the retina in diabetic retinopathy, and the unwanted vessel growth in chronic inflammatory diseases. Adhesion of endothelial cells to ECM and attainment of an The hypothesis that angiogenic diseases, in particular tumor appropriate cellular shape has been known for many years to growth and metastases, may be alleviated by inhibiting the an- be crucial for endothelial cell growth, differentiation, and sur- giogenic responses (1) has prompted many to investigate the vival.
    [Show full text]
  • Laminin-Binding Integrin A7,1: Functional Characterization and Expression in Normal and Malignant Melanocytes
    CELL REGULATION, Vol. 2, 805-817, October 1991 Laminin-binding integrin a7,1: functional characterization and expression in normal and malignant melanocytes Randall H. Kramer,*t$ Mai P. Vu,* increased attachment to laminin exhibit much Yao-Fen Cheng,* Daniel M. Ramos,* higher metastatic potential in lung colonization Rupert Timpl,§ and Nahid Waleh 11 assays (reviewed in Liotta et aL, 1986). Fur- *Departments of Stomatology and Anatomy thermore, the presence of intact laminin will en- and the tCardiovascular Research Institute hance lung colonization (Barsky et aL., 1984). University of California These results and others strongly suggest that San Francisco, California 94143 melanoma cells interact with laminin-rich base- §Max-Planck-lnstitut fur Biochemie ment membrane and that this interaction facil- Martinsried, Germany itates their vascular arrest and colonization of IISRI International distant sites. Menlo Park, California 94025 During tissue invasion, metastatic melanoma cells interact with different types of extracellular matrix, including the interstitium and basement A novel integrin, a,#,, that specifically binds with membranes. It is expected, then, that these high affinity to laminin has been identified on mel- malignant cells will express surface adhesion anoma cells. This complex was purified from both receptors with diverse ligand specificities human and murine melanoma cells by laminin-af- (Ruoslahti and Giancotti, 1989). The integrin finity chromatography, and the a7 subunit was re- family of adhesion receptors consists of a large covered after gel electrophoresis. N-terminal amino number of heterodimer receptors that appear acid sequence analysis of the a7 subunit from both to mediate many of the cell-extracellular matrix human and mouse cells verifies that this integrin interactions for melanoma and other cell types is distinct from other a chains in the #I family, al- (Hynes, 1987; Ruoslahti and Pierschbacher, though strikingly similar to the as subunit.
    [Show full text]
  • Integrin Activity 7Β , and 3Β , 2 Β Chemoattractant-Stimulated Differential Regulation Of
    Differential Regulation of Chemoattractant-Stimulated β2, β3, and β7 Integrin Activity This information is current as Chanchal Sadhu, Boris Masinovsky and Donald E. Staunton of September 26, 2021. J Immunol 1998; 160:5622-5628; ; http://www.jimmunol.org/content/160/11/5622 Downloaded from References This article cites 24 articles, 11 of which you can access for free at: http://www.jimmunol.org/content/160/11/5622.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 26, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. b b Differential Regulation of Chemoattractant-Stimulated 2, 3, b and 7 Integrin Activity Chanchal Sadhu,1 Boris Masinovsky, and Donald E. Staunton Leukocyte adhesion to endothelium and extravasation are dynamic processes that require activation of integrins. Chemoattrac- tants such as IL-8 and FMLP are potent activators of leukocyte integrins. To compare the chemoattractant-stimulated activation a b a b a b of three integrins, 4 7, L 2, and V 3, in the same cellular context, we expressed an IL-8 receptor (IL-8RA) and FMLP receptor a b a b (FPR) in the lymphoid cell line JY.
    [Show full text]
  • Cell Adhesion Molecules in Normal Skin and Melanoma
    biomolecules Review Cell Adhesion Molecules in Normal Skin and Melanoma Cian D’Arcy and Christina Kiel * Systems Biology Ireland & UCD Charles Institute of Dermatology, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +353-1-716-6344 Abstract: Cell adhesion molecules (CAMs) of the cadherin, integrin, immunoglobulin, and selectin protein families are indispensable for the formation and maintenance of multicellular tissues, espe- cially epithelia. In the epidermis, they are involved in cell–cell contacts and in cellular interactions with the extracellular matrix (ECM), thereby contributing to the structural integrity and barrier for- mation of the skin. Bulk and single cell RNA sequencing data show that >170 CAMs are expressed in the healthy human skin, with high expression levels in melanocytes, keratinocytes, endothelial, and smooth muscle cells. Alterations in expression levels of CAMs are involved in melanoma propagation, interaction with the microenvironment, and metastasis. Recent mechanistic analyses together with protein and gene expression data provide a better picture of the role of CAMs in the context of skin physiology and melanoma. Here, we review progress in the field and discuss molecular mechanisms in light of gene expression profiles, including recent single cell RNA expression information. We highlight key adhesion molecules in melanoma, which can guide the identification of pathways and Citation: D’Arcy, C.; Kiel, C. Cell strategies for novel anti-melanoma therapies. Adhesion Molecules in Normal Skin and Melanoma. Biomolecules 2021, 11, Keywords: cadherins; GTEx consortium; Human Protein Atlas; integrins; melanocytes; single cell 1213. https://doi.org/10.3390/ RNA sequencing; selectins; tumour microenvironment biom11081213 Academic Editor: Sang-Han Lee 1.
    [Show full text]
  • Cx3cr1 Mediates the Development of Monocyte-Derived Dendritic Cells During Hepatic Inflammation
    CX3CR1 MEDIATES THE DEVELOPMENT OF MONOCYTE-DERIVED DENDRITIC CELLS DURING HEPATIC INFLAMMATION. Supplementary material Supplementary Figure 1: Liver CD45+ myeloid cells were pre-gated for Ly6G negative cells for excluding granulocytes and HDCs subsequently analyzed among the cells that were CD11c+ and had high expression of MHCII. Supplementary Table 1 low/- high + Changes in gene expression between CX3CR1 and CX3CR1 CD11b myeloid hepatic dendritic cells (HDCs) from CCl4-treated mice high Genes up-regulated in CX3CR1 HDCs Gene Fold changes P value Full name App 4,01702 5,89E-05 amyloid beta (A4) precursor protein C1qa 9,75881 1,69E-22 complement component 1, q subcomponent, alpha polypeptide C1qb 9,19882 3,62E-20 complement component 1, q subcomponent, beta polypeptide Ccl12 2,51899 0,011769 chemokine (C-C motif) ligand 12 Ccl2 6,53486 6,37E-11 chemokine (C-C motif) ligand 2 Ccl3 4,99649 5,84E-07 chemokine (C-C motif) ligand 3 Ccl4 4,42552 9,62E-06 chemokine (C-C motif) ligand 4 Ccl6 3,9311 8,46E-05 chemokine (C-C motif) ligand 6 Ccl7 2,60184 0,009272 chemokine (C-C motif) ligand 7 Ccl9 4,17294 3,01E-05 chemokine (C-C motif) ligand 9 Ccr2 3,35195 0,000802 chemokine (C-C motif) receptor 2 Ccr5 3,23358 0,001222 chemokine (C-C motif) receptor 5 Cd14 6,13325 8,61E-10 CD14 antigen Cd36 2,94367 0,003243 CD36 antigen Cd44 4,89958 9,60E-07 CD44 antigen Cd81 6,49623 8,24E-11 CD81 antigen Cd9 3,06253 0,002195 CD9 antigen Cdkn1a 4,65279 3,27E-06 cyclin-dependent kinase inhibitor 1A (P21) Cebpb 6,6083 3,89E-11 CCAAT/enhancer binding protein (C/EBP),
    [Show full text]
  • Regulation of Cellular Adhesion Molecule Expression in Murine Oocytes, Peri-Implantation and Post-Implantation Embryos
    Cell Research (2002); 12(5-6):373-383 http://www.cell-research.com Regulation of cellular adhesion molecule expression in murine oocytes, peri-implantation and post-implantation embryos 1,2 1,2 2 1, DAVID P LU , LINA TIAN , CHRIS O NEILL , NICHOLAS JC KING * 1Department of Pathology, University of Sydney, NSW 2006 Australia 2Human Reproduction Unit, Department of Physiology, University of Sydney, Royal North Shore Hospital, NSW 2065, Australia ABSTRACT Expression of the adhesion molecules, ICAM-1, VCAM-1, NCAM, CD44, CD49d (VLA-4, α chain), and CD11a (LFA-1, α chain) on mouse oocytes, and pre- and peri-implantation stage embryos was examined by quantitative indirect immunofluorescence microscopy. ICAM-1 was most strongly expressed at the oocyte stage, gradually declining almost to undetectable levels by the expanded blastocyst stage. NCAM, also ex- pressed maximally on the oocyte, declined to undetectable levels beyond the morula stage. On the other hand, CD44 declined from highest expression at the oocyte stage to show a second maximum at the com- pacted 8-cell/morula. This molecule exhibited high expression around contact areas between trophectoderm and zona pellucida during blastocyst hatching. CD49d was highly expressed in the oocyte, remained signifi- cantly expressed throughout and after blastocyst hatching was expressed on the polar trophectoderm. Like CD44, CD49d declined to undetectable levels at the blastocyst outgrowth stage. Expression of both VCAM- 1 and CD11a was undetectable throughout. The diametrical temporal expression pattern of ICAM-1 and NCAM compared to CD44 and CD49d suggest that dynamic changes in expression of adhesion molecules may be important for interaction of the embryo with the maternal cellular environment as well as for continuing development and survival of the early embryo.
    [Show full text]
  • Integrins As Therapeutic Targets: Successes and Cancers
    cancers Review Integrins as Therapeutic Targets: Successes and Cancers Sabine Raab-Westphal 1, John F. Marshall 2 and Simon L. Goodman 3,* 1 Translational In Vivo Pharmacology, Translational Innovation Platform Oncology, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany; [email protected] 2 Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK; [email protected] 3 Translational and Biomarkers Research, Translational Innovation Platform Oncology, Merck KGaA, 64293 Darmstadt, Germany * Correspondence: [email protected]; Tel.: +49-6155-831931 Academic Editor: Helen M. Sheldrake Received: 22 July 2017; Accepted: 14 August 2017; Published: 23 August 2017 Abstract: Integrins are transmembrane receptors that are central to the biology of many human pathologies. Classically mediating cell-extracellular matrix and cell-cell interaction, and with an emerging role as local activators of TGFβ, they influence cancer, fibrosis, thrombosis and inflammation. Their ligand binding and some regulatory sites are extracellular and sensitive to pharmacological intervention, as proven by the clinical success of seven drugs targeting them. The six drugs on the market in 2016 generated revenues of some US$3.5 billion, mainly from inhibitors of α4-series integrins. In this review we examine the current developments in integrin therapeutics, especially in cancer, and comment on the health economic implications of these developments. Keywords: integrin; therapy; clinical trial; efficacy; health care economics 1. Introduction Integrins are heterodimeric cell-surface adhesion molecules found on all nucleated cells. They integrate processes in the intracellular compartment with the extracellular environment. The 18 α- and 8 β-subunits form 24 different heterodimers each having functional and tissue specificity (reviewed in [1,2]).
    [Show full text]